ATE276266T1 - Nukleinsäureliganden für gewebeziele - Google Patents
Nukleinsäureliganden für gewebezieleInfo
- Publication number
- ATE276266T1 ATE276266T1 AT96915422T AT96915422T ATE276266T1 AT E276266 T1 ATE276266 T1 AT E276266T1 AT 96915422 T AT96915422 T AT 96915422T AT 96915422 T AT96915422 T AT 96915422T AT E276266 T1 ATE276266 T1 AT E276266T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleic acid
- tissue targets
- acid ligands
- cells
- ligands
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title abstract 5
- 108020004707 nucleic acids Proteins 0.000 title abstract 3
- 150000007523 nucleic acids Chemical class 0.000 title abstract 3
- 102000039446 nucleic acids Human genes 0.000 title abstract 3
- 210000004027 cell Anatomy 0.000 abstract 3
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 abstract 2
- 102000009123 Fibrin Human genes 0.000 abstract 1
- 108010073385 Fibrin Proteins 0.000 abstract 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 210000001715 carotid artery Anatomy 0.000 abstract 1
- 229950003499 fibrin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3517—Marker; Tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
- C12N2320/13—Applications; Uses in screening processes in a process of directed evolution, e.g. SELEX, acquiring a new function
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/433,124 US5750342A (en) | 1990-06-11 | 1995-05-03 | Nucleic acid ligands of tissue target |
| US08/433,126 US5688935A (en) | 1990-06-11 | 1995-05-03 | Nucleic acid ligands of tissue target |
| PCT/US1996/006059 WO1996034874A1 (en) | 1995-05-03 | 1996-05-01 | Nucleic acid ligands of tissue target |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE276266T1 true ATE276266T1 (de) | 2004-10-15 |
Family
ID=27029755
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96915422T ATE276266T1 (de) | 1995-05-03 | 1996-05-01 | Nukleinsäureliganden für gewebeziele |
| AT04015822T ATE401424T1 (de) | 1995-05-03 | 1996-05-01 | Verfahren zur identifizierung von nukleinsäureliganden für gewebsziele |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04015822T ATE401424T1 (de) | 1995-05-03 | 1996-05-01 | Verfahren zur identifizierung von nukleinsäureliganden für gewebsziele |
Country Status (9)
| Country | Link |
|---|---|
| EP (3) | EP2000534A3 (de) |
| JP (1) | JPH11504812A (de) |
| AT (2) | ATE276266T1 (de) |
| AU (1) | AU727460B2 (de) |
| CA (2) | CA2219106C (de) |
| DE (2) | DE69633386T2 (de) |
| DK (1) | DK1564290T3 (de) |
| ES (1) | ES2310695T3 (de) |
| WO (1) | WO1996034874A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716580B2 (en) | 1990-06-11 | 2004-04-06 | Somalogic, Inc. | Method for the automated generation of nucleic acid ligands |
| US6127119A (en) * | 1990-06-11 | 2000-10-03 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands of tissue target |
| US6346611B1 (en) * | 1990-06-11 | 2002-02-12 | Gilead Sciences, Inc. | High affinity TGfβ nucleic acid ligands and inhibitors |
| US6068829A (en) | 1995-09-11 | 2000-05-30 | The Burnham Institute | Method of identifying molecules that home to a selected organ in vivo |
| US20070166741A1 (en) | 1998-12-14 | 2007-07-19 | Somalogic, Incorporated | Multiplexed analyses of test samples |
| US6232287B1 (en) | 1998-03-13 | 2001-05-15 | The Burnham Institute | Molecules that home to various selected organs or tissues |
| AU777823B2 (en) * | 1999-01-19 | 2004-11-04 | Somalogic, Inc. | Method and apparatus for the automated generation of nucleic acid ligands |
| US7452964B2 (en) | 2001-09-07 | 2008-11-18 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| US7420030B2 (en) | 2000-09-08 | 2008-09-02 | The Board Of Regents Of The University Of Texas System | Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
| US20040170955A1 (en) | 2000-09-08 | 2004-09-02 | Wadih Arap | Human and mouse targeting peptides identified by phage display |
| AU2775402A (en) * | 2001-06-29 | 2003-01-02 | Medimolecular Pty Ltd | Nucleic acid ligands to complex targets |
| US8030465B2 (en) | 2001-06-29 | 2011-10-04 | Medimolecular Pty Ltd | Nucleic acid ligands to complex targets |
| US20110136099A1 (en) | 2007-01-16 | 2011-06-09 | Somalogic, Inc. | Multiplexed Analyses of Test Samples |
| US7855054B2 (en) | 2007-01-16 | 2010-12-21 | Somalogic, Inc. | Multiplexed analyses of test samples |
| US8906700B2 (en) | 2007-11-06 | 2014-12-09 | Ambergen, Inc. | Methods and compositions for phototransfer |
| EP2078751A1 (de) * | 2008-01-11 | 2009-07-15 | Commissariat A L'energie Atomique | Spezifische zur Unterdrückung der Zellmigration und -invasion durch Krebszellen erzeugte Aptamere, Verfahren zur Auswahl derartiger Aptamere und ihre Verwendung |
| EP2159286A1 (de) * | 2008-09-01 | 2010-03-03 | Consiglio Nazionale Delle Ricerche | Verfahren zur Gewinnung von Oligonucleotid-Aptameren und Verwendungen damit |
| CA2928207C (en) | 2013-11-21 | 2020-09-15 | Somalogic, Inc. | Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE318832T1 (de) | 1990-06-11 | 2006-03-15 | Gilead Sciences Inc | Verfahren zur vervendung von nukleinsäureliganden |
| US5637459A (en) | 1990-06-11 | 1997-06-10 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chimeric selex |
| US5705337A (en) | 1990-06-11 | 1998-01-06 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| US5496938A (en) | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
| US5683867A (en) | 1990-06-11 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: blended SELEX |
| IE920562A1 (en) * | 1991-02-21 | 1992-08-26 | Gilead Sciences | Aptamer specific for biomolecules and method of making |
| IL101038A0 (en) * | 1991-02-21 | 1992-11-15 | Gilead Sciences Inc | Agent specific for trombin and its use |
| US5726014A (en) * | 1991-06-27 | 1998-03-10 | Genelabs Technologies, Inc. | Screening assay for the detection of DNA-binding molecules |
| AU7102594A (en) * | 1993-06-09 | 1995-01-03 | Pharmagenics, Inc. | Oligonucleotides which inhibit hiv protease function |
| EP0823914B1 (de) * | 1995-05-03 | 2004-08-25 | Gilead Sciences, Inc. | Systematische evoultion von liganden durch exponentielle anreicherung: gewebe-selex |
| US20170110787A1 (en) | 2015-10-14 | 2017-04-20 | Apple Inc. | Electronic Devices With Millimeter Wave Antennas And Metal Housings |
| US12393593B2 (en) | 2023-09-12 | 2025-08-19 | Optum, Inc. | Priority-driven federated query-based data caching |
-
1996
- 1996-05-01 EP EP08012656A patent/EP2000534A3/de not_active Withdrawn
- 1996-05-01 CA CA002219106A patent/CA2219106C/en not_active Expired - Lifetime
- 1996-05-01 DE DE69633386T patent/DE69633386T2/de not_active Expired - Lifetime
- 1996-05-01 AT AT96915422T patent/ATE276266T1/de not_active IP Right Cessation
- 1996-05-01 AU AU57200/96A patent/AU727460B2/en not_active Expired
- 1996-05-01 WO PCT/US1996/006059 patent/WO1996034874A1/en not_active Ceased
- 1996-05-01 AT AT04015822T patent/ATE401424T1/de not_active IP Right Cessation
- 1996-05-01 EP EP96915422A patent/EP0824540B1/de not_active Expired - Lifetime
- 1996-05-01 DE DE69637605T patent/DE69637605D1/de not_active Expired - Lifetime
- 1996-05-01 JP JP8533450A patent/JPH11504812A/ja not_active Ceased
- 1996-05-01 EP EP04015822A patent/EP1564290B1/de not_active Expired - Lifetime
- 1996-05-01 ES ES04015822T patent/ES2310695T3/es not_active Expired - Lifetime
- 1996-05-01 CA CA002641149A patent/CA2641149A1/en not_active Abandoned
- 1996-05-01 DK DK04015822T patent/DK1564290T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1564290A3 (de) | 2006-02-01 |
| EP0824540A1 (de) | 1998-02-25 |
| WO1996034874A1 (en) | 1996-11-07 |
| EP2000534A2 (de) | 2008-12-10 |
| DE69633386T2 (de) | 2005-09-22 |
| CA2219106A1 (en) | 1996-11-07 |
| ES2310695T3 (es) | 2009-01-16 |
| EP1564290A2 (de) | 2005-08-17 |
| DE69637605D1 (de) | 2008-08-28 |
| EP0824540B1 (de) | 2004-09-15 |
| EP0824540A4 (de) | 2003-04-23 |
| JPH11504812A (ja) | 1999-05-11 |
| AU727460B2 (en) | 2000-12-14 |
| ATE401424T1 (de) | 2008-08-15 |
| CA2219106C (en) | 2008-09-23 |
| CA2641149A1 (en) | 1996-11-07 |
| EP1564290B1 (de) | 2008-07-16 |
| DK1564290T3 (da) | 2008-11-17 |
| EP2000534A3 (de) | 2009-09-02 |
| AU5720096A (en) | 1996-11-21 |
| DE69633386D1 (de) | 2004-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69633386D1 (de) | Nukleinsäureliganden für gewebeziele | |
| CA2219807A1 (en) | Systematic evolution of ligands by exponential enrichment: tissue selex | |
| DE69434942D1 (de) | Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben | |
| ATE466960T1 (de) | Verwendung von nukleinsäureliganden in der durchflusszytometrie | |
| CA2002868A1 (en) | Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors | |
| MX9100052A (es) | Biblioteca(o conjunto)de bio-oligomeros al azar,un metodo de sintesis de los mismos y un metodo de uso de los mismos | |
| BR8500963A (pt) | Aparelho grampeador cirurgico,aparelho de acionamento para grampeador cirurgico,encadeamento acionador para operar acionador de grampeador cirurgico,encadeamento de quatro barras para operar acionador de grampo de grampeador cirurgico,processo para mover grampos cirurgicos,processo de distribuicao e formacao de grampos cirurgicos e processo de captacao de grampos cirurgicos | |
| ID28623A (id) | Turunan 2-amino-tiazol, proses pembuatannya, dan penggunaannya sebagai zat anti tumor | |
| DE69940198D1 (de) | Mikrovorrichtung zum screening von biomolekülen | |
| ATE278015T1 (de) | Effektor-proteine für rapamycin | |
| DE68915258D1 (de) | Verfahren zur katalytischen Oligomerisierung von Olefinen. | |
| WO2001012659A3 (en) | Human dna sequences | |
| DE3879209D1 (de) | Filtereinheiten fuer die vorbereitung von biologischen proben. | |
| EP1153298A4 (de) | Kombinatorische, komplexe kohlenhydrat-bibliotheken und verfahren zur herstellung und zum gebrauch davon | |
| DE69903399D1 (de) | Prepolymerisierte katalysatorkomponente für die polymerisierung von olefinen | |
| WO1988007576A3 (en) | Vascular anticoagulant proteins, dnas which code for them, manufacture and application thereof | |
| ID21337A (id) | Katalis terdorong, proses pembuatannya, dan penggunaannya dalam oksiklorinasi etilene | |
| ATE355295T1 (de) | Synthese von oligosacchariden, reagenzien und verfahren | |
| ATE179712T1 (de) | Analoge für spezifische oligosaccharid-protein- wechselwirkungen und ihre verwendungen | |
| DE69008825D1 (de) | Verfahren zur Reinigung von Phagen-DNA. | |
| DE3789676D1 (de) | Diagnostisches Verfahren für Gonorrhoe durch Proben von IgA1-Fragmenten. | |
| EP1019092A4 (de) | Therapeutische und diagnostische mittel für krankheiten mit gestörter glukose-toleranz | |
| ID29565A (id) | Terpolimer-terpolimer etilena dan proses pembuatannya | |
| DE69009050D1 (de) | Verfahren zur stabilisierung der hybridisierung von komplementären polynukleotidsequenzen. | |
| FI873674A0 (fi) | -2-plasmin-inhibitorliknande protein kodande dna. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |